CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 265 filers reported holding CONMED CORP in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $406,148 | +75.1% | 4,582 | +58.1% | 0.00% | +50.0% |
| Q3 2022 | $232,000 | -91.3% | 2,898 | -89.6% | 0.00% | -92.3% |
| Q2 2022 | $2,676,000 | -59.1% | 27,954 | -36.5% | 0.03% | -55.9% |
| Q1 2022 | $6,536,000 | -37.6% | 43,999 | -40.5% | 0.06% | -37.9% |
| Q4 2021 | $10,482,000 | +655.2% | 73,936 | +632.0% | 0.10% | +533.3% |
| Q2 2021 | $1,388,000 | -67.0% | 10,100 | -68.6% | 0.02% | -70.6% |
| Q1 2021 | $4,206,000 | +507.8% | 32,213 | +266.1% | 0.05% | +292.3% |
| Q3 2020 | $692,000 | -77.2% | 8,800 | -79.1% | 0.01% | -68.3% |
| Q2 2020 | $3,034,000 | +147.5% | 42,144 | +96.9% | 0.04% | -46.8% |
| Q1 2020 | $1,226,000 | +108.1% | 21,400 | +305.9% | 0.08% | +450.0% |
| Q4 2019 | $589,000 | +145.4% | 5,272 | +110.9% | 0.01% | +100.0% |
| Q3 2019 | $240,000 | -11.4% | 2,500 | -32.4% | 0.01% | -53.3% |
| Q2 2018 | $271,000 | -43.4% | 3,700 | -51.1% | 0.02% | -58.3% |
| Q1 2018 | $479,000 | -43.5% | 7,562 | -57.4% | 0.04% | -81.1% |
| Q2 2016 | $848,000 | – | 17,770 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |